We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.
- Authors
Damaj, Gandhi; Gressin, Rémy; Bouabdallah, Krimo; Cartron, Guillaume; Choufi, Bachra; Gyan, Emmanuel; Banos, Anne; Jaccard, Arnaud; Park, Sophie; Tournilhac, Olivier; Schiano-de Collela, Jean-Marc; Voillat, Laurent; Joly, Bertrand; Le Gouill, Steven; Saad, Alain; Cony-Makhoul, Pascale; Vilque, Jean-Pierre; Sanhes, Laurence; Schmidt-Tanguy, Aline; Bubenheim, Michael; Houot, Roch; Diouf, Momar; Marolleau, Jean-Pierre; Béné, Marie-Christine; Martin, Antoine; Lamy, Thierry
- Abstract
To determine the efficacy and safety of bendamustine as a single agent in refractory or relapsed T-cell lymphomas.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Vol 31, Issue 1, p104
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2012.43.7285